Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The investigators hypothesize that the concentration-time profile of raltegravir is different in cells than that in plasma. Intracellular raltegravir concentrations may be higher and its half-life longer than in plasma. This may explain the efficacy of raltegravir despite variable plasma concentrations.
Critère d'inclusion
- Human Immunodeficiency Virus